Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 7/19/2021 | $6.70 → $8.40 | Neutral → Buy | Goldman Sachs |
AUSTIN, Texas, March 22, 2022 /PRNewswire/ -- Citizens, Inc. ("Citizens" or the "Company") (NYSE:CIA), has appointed Gateway Group, Inc. ("Gateway"), a leading strategic financial communications and capital markets advisory firm, to manage its new investor relations program. Gateway and Citizens are partnering to create and implement a comprehensive strategic communication and outreach program. The objectives of the new program are to refine Citizens' overall company messaging and corporate positioning, ensure its investment highlights are properly communicated, and to increas
AUSTIN, Texas, Aug. 2, 2021 /PRNewswire/ -- Citizens, Inc. (NYSE:CIA) announces the appointment of three new board members, effective August 1, 2021, demonstrating a continued commitment to Board diversity and an inclusive culture. The new members bring years of insurance experience to the Board, each from a different perspective, bringing unique expertise to enhance the Board's ability to effectively oversee the Company's business operations and guide management's efforts to achieve long-term strategic objectives. New Board members: Cindy Davis is a seasoned executive in the
4 - CITIZENS, INC. (0000024090) (Issuer)
4 - CITIZENS, INC. (0000024090) (Issuer)
4 - CITIZENS, INC. (0000024090) (Issuer)
Goldman Sachs upgraded Champion Iron from Neutral to Buy and set a new price target of $8.40 from $6.70 previously
TD Securities reiterated coverage of Champion Iron Limited (CIA.TO) with a rating of Buy and set a new price target of $7.00 from $6.50 previously
4 - CITIZENS, INC. (0000024090) (Issuer)
4 - CITIZENS, INC. (0000024090) (Issuer)
4 - CITIZENS, INC. (0000024090) (Issuer)
Austin, Texas--(Newsfile Corp. - November 7, 2024) - Citizens, Inc. (NYSE:CIA), a leading diversified financial services company specializing in life, living benefits and final expense insurance, today reported results for the third quarter ended September 30, 2024."We are thrilled to report strong sales momentum and exceptional execution in the third quarter and throughout 2024 with several significant developments. Our strategic roadmap is designed to deliver improved operating results and sustainable growth in book value per share. First year premiums have increased year-over-year for eight consecutive quarters. Insurance issued increased 75% in Q3 2024 - our fourth consecutive quarter of
Emerging Growth Virtual Conference on October 31, 2024Singular Research Virtual Conference on December 12, 2024Austin, Texas--(Newsfile Corp. - October 31, 2024) - Citizens, Inc. (NYSE:CIA), a leading diversified financial services company specializing in life, living benefits, and final expense insurance, today announced management's plan for participation in upcoming investor conferences.Emerging Growth Virtual Conference on October 31, 2024Citizens management plans to present at the Emerging Growth Virtual Conference on October 31 at 2:25 ET. The live, interactive webcast and slide presentation will be accessible on the Company's Investor Relations website under the Events tab HERE. The w
MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ:NRXP) will appear on the Emerging Growth Conference today in response to multiple requests and investor demand. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Jonathan Javitt, MD, MPH, Founder and Chairman will be discussing its first steps towards acquisition through its HOPE Therapeutics subsidiary of a national network of interventional psychiatry clinics focused on tr
The Dow Jones index closed higher by more than 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform. ARCA biopharma The Trade: ARCA biopharma, Inc. (NASDAQ:ABIO) 10% owner Janus Henderson Biotech Innovation Master Fund Ltd bought a total of 408,777 shares at an average price of $3.49. To acquire these shares, it cost around $1.4 million. W
Jon Stenberg is an experienced growth leader to further leverage Citizens' opportunitiesGerald W. Shields continues as Vice Chairman of the BoardAustin, Texas--(Newsfile Corp. - July 1, 2024) - Citizens, Inc. (NYSE:CIA), a leading diversified financial services company specializing in life, living benefits, and final expense insurance, today announces the planned transition of the Chief Executive Officer role. Jon Stenberg, who currently serves as Citizens' President, is appointed to the additional role of Chief Executive Officer effective July 1, 2024. Gerald W. Shields, who has served as CEO and Vice Chairman since 2020, will continue as Vice Chairman of the Company's Board of Directors.
The Federal Reserve Board’s annual bank stress test Wednesday reveals that while large banks face greater projected losses than last year in a downturn scenario, they remain well-positioned to endure a severe recession and maintain their capital requirements above minimum thresholds. “This year’s stress test shows that large banks have sufficient capital to withstand a highly stressful scenario and meet their minimum capital ratios,” said the Fed’s vice chair for supervision Michael S. Barr. Although this year’s stress test adverse scenario is as severe as last year’s, it resulted in greater losses due to slightly riskier bank balance sheets and increased expenses, he said. Reflec
10-Q - CITIZENS, INC. (0000024090) (Filer)
8-K - CITIZENS, INC. (0000024090) (Filer)
10-Q - CITIZENS, INC. (0000024090) (Filer)